Volume 2.34 | Sep 9

Human Immunology News 2.34 September 9, 2014
Human Immunology News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  HIN on Twitter
 
TOP STORY
Human Dermal CD14+ Cells Are a Transient Population of Monocyte-Derived Macrophages
Researchers demonstrate that human dermal CD14+ cells are a tissue-resident population of monocyte-derived macrophages with a short half-life of <6 days. The decline and reconstitution kinetics of human blood CD14+ monocytes and dermal CD14+ cells in vivo supported their precursor-progeny relationship. [Immunity]
Full Article | Graphical Abstract
Complimentary Wallchart:  Human Hematopoietic Progenitors.  Request Your Copy Today.
 
PUBLICATIONS (Ranked by impact factor of the journal)
Moderate Hypoxia Potentiates Interleukin-1β Production in Activated Human Macrophages
Researchers demonstrate that hypoxia enhances pro-interleukin-1β protein, but not mRNA, expression in LPS-stimulated human macrophages. [Circ Res] Abstract

Stat3 Promotes IL-10 Expression in Lupus T Cells through trans-Activation and Chromatin Remodeling
Scientists aimed to determine molecular events governing T cell-derived IL-10 expression in health and disease. They linked reduced DNA methylation of the IL10 gene with increased recruitment of Stat family transcription factors. [Proc Natl Acad Sci USA] Abstract

Prognostic Significance of FOXP3+ Tumor Infiltrating Lymphocytes in Breast Cancer Depends on Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Expression Status and Concurrent Cytotoxic T-Cell Infiltration
FOXP3+ tumor infiltrating lymphocytes were assessed by immunohistochemistry on tissue microarrays constructed from a well-defined cohort of 3,992 breast cancer patients linked to detailed demographic, biomarker, treatment and outcome data. [Breast Cancer Res] Abstract | Full Article

Endothelial Microparticles Interact with and Support the Proliferation of T Cells
Given the recently described role for human brain microvascular endothelial cells (HBEC) in modulating immune responses, researchers investigated how HBEC-derived microparticles (MP) could interact with and support the proliferation of T cells. Like their mother cells, endothelial MP expressed molecules important for Ag presentation and T cell costimulation, that is, β2-microglobulin, MHC II, CD40, and ICOSL. [J Immunol] Abstract

TLR9 Transcriptional Regulation in Response to Double-Stranded DNA Viruses
Researchers examined the relationship between activation and the transcriptional regulation of TLR9. They demonstrate that infection of primary human epithelial cells, B cells, and plasmacytoid dendritic cells with dsDNA viruses induces a regulatory temporary negative-feedback loop that blocks TLR9 transcription and function. [J Immunol] Abstract

Cigarette Smoke Induced DAMP Release from Necrotic Neutrophils Triggers Pro-Inflammatory Mediator Release
In human peripheral blood neutrophils, mitochondrial membrane potential, apoptosis/necrosis markers, caspase activity and DAMP release were studied after cigarette smoke exposure. [Am J Respir Cell Mol Biol] Abstract

Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response through Multiple Mechanisms in Macrophages
Researchers examined the effect of apigenin on LPS-induced inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages and mouse J774A.1 macrophages. [PLoS One] Full Article

Severely Depressed Interleukin-17 Production by Human Neonatal Mononuclear Cells
Scientists examined neonatal production of IL-17 in mixed mononuclear cells isolated from umbilical cord blood for comparison with adult peripheral blood mononuclear cell controls. IL-17 production was profoundly diminished in mixed mononuclear cells isolated from cord blood when compared with mixed mononuclear cells from adult blood. [Pediatr Res] Abstract

Subscribe to our sister publications: Immunology of Infectious Disease News and Immune Regulation News!

Find protocols, tools and video at the Human Immunology Portal
 
REVIEWS
Hydrogels and Scaffolds for Immunomodulation
The authors provide an insight into emerging hydrogel and scaffold based immunomodulatory approaches that continue to demonstrate efficacy against immune associated diseases. [Adv Mater] Abstract

Visit our reviews page to see a complete list of reviews in the human immunology research field.

Antibody Engineering & Therapeutics - December 7-11, 2014
 
SCIENCE NEWS
Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients
A new breast cancer vaccine candidate provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug. [Press release from The University of Texas MD Anderson Cancer Center discussing research presented at the 2014 American Society of Clinical Oncology’s Breast Cancer Symposium, San Francisco] Press Release

From our sponsor: Free Nature Reviews Immunology poster – Immune Response to HIV. Request a copy.
 
INDUSTRY NEWS
Nuvo Research® Completes Enrolment in WF10™ Phase II Clinical Trial
Nuvo Research Inc. announced that it has completed enrolment in its Phase II clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis. [Nuvo Research Inc.] Press Release

EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology
EMD Serono, Inc. announced that Drew Young has joined the company as Senior Vice President, Neurology and Immunology. [EMD Serono, Inc.] Press Release

Ascend Biopharmaceuticals Clinical Trial Program Update
Ascend Biopharmaceuticals plans to begin a Phase II clinical trial on ASN-002, an injectable immunotherapy for basal cell carcinoma, by 2015. Ascend has also announced plans to begin a Phase Ib study on a therapeutic cancer vaccine for breast cancer, ASN-004, in the second half of 2015. [Ascend Biopharmaceuticals Ltd.]
Press Release

Ludwig Cancer Research and Cancer Research Institute Collaborate on Evaluation of VentiRx’s Investigational Immunotherapy
The nonprofits Ludwig Cancer Research and the Cancer Research Institute (CRI) announced an agreement with VentiRx Pharmaceuticals Inc. to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships. [Ludwig Institute for Cancer Research Ltd.] Press Release
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 9th European Mucosal Immunology Group Meeting
October 9-12, 2014
Glasgow, Scotland

Visit our events page to see a complete list of events in the human immunology community.
 
JOB OPPORTUNITIES
NEW Research Scientist – Immunology (Beijing Genomics Institute)

NEW Postdoctoral Fellowship – Immunology (Huazhong University of Science and Technology)

Postdoctoral Position – Transplantation Aspects of Hepatocytes Derived from Human Pluripotent Stem Cells (INSERM UMR 1064 )

Postdoctoral Position – Human Mucosal Immunology (INSERM)

Postdoctoral Fellow – Molecular Aspects of Autoimmunity (Singapore Immunology Network A*STAR)

Postdoctoral Scientist – Pathways/Targets in the Blood Transcriptome of Human Tuberculosis (Medical Research Council)

Postdoctoral Position – Macrophage Functions (Cochin Institute)

Senior Manager – Inflammation, Fibrosis Biomarkers (Gilead Sciences)

Scientist – Recombinant Molecules and Antibodies (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Human Immunology News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Human Immunology News: Archives | Events | Contact Us